| 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 |
---|---|---|---|---|---|---|---|---|---|---|---|
Brazil retail | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â |
Alpha-glucosidase inhibitors | 2.18 | 2.12 | 2.06 | 1.90 | 2.03 | 1.89 | 1.55 | 1.45 | 1.21 | 0.81 | 0.62 |
Biguanides | 34.56 | 37.50 | 40.94 | 43.61 | 45.70 | 48.61 | 49.55 | 49.56 | 51.39 | 54.21 | 57.53 |
DPP4 inhibitors | 0 | 0 | 0 | 0 | 0 | 0.77 | 2.25 | 2.70 | 2.48 | 2.43 | 2.77 |
Fixed dose combinations** | 1.51 | 4.35 | 6.87 | 8.29 | 9.04 | 8.50 | 9.26 | 10.07 | 9.50 | 8.32 | 7.60 |
Non-sulfonylurea secretagogues | 3.55 | 3.58 | 3.28 | 2.94 | 2.76 | 2.19 | 1.55 | 1.25 | 0.98 | 0.58 | 0.33 |
Thiazolidinediones | 0.73 | 0.86 | 0.93 | 1.14 | 1.55 | 1.34 | 0.99 | 0.93 | 0.76 | 0.47 | 0.46 |
Sulfonylureas | 57.48 | 51.60 | 45.93 | 42.12 | 38.92 | 36.70 | 34.85 | 34.04 | 33.68 | 33.19 | 30.69 |
China hospital | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â |
Alpha-glucosidase inhibitors | 10.50 | 13.48 | 16.65 | 18.41 | 19.76 | 21.06 | 21.95 | 23.16 | 25.48 | 26.94 | 27.35 |
Biguanides | 45.41 | 43.48 | 39.27 | 38.03 | 37.34 | 36.57 | 35.68 | 34.31 | 32.93 | 33.22 | 34.64 |
DPP4 inhibitors | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.01 | 0.06 | 0.15 |
Fixed dose combinations** | 0 | 0 | 0 | 0 | 0 | 0.01 | 0.03 | 0.15 | 0.21 | 0.13 | 0.15 |
Non-sulfonylurea secretagogues | 2.26 | 3.85 | 5.58 | 6.98 | 8.31 | 10.33 | 12.05 | 13.72 | 14.72 | 15.16 | 14.13 |
Thiazolidinediones | 0.37 | 0.66 | 0.93 | 1.26 | 2.35 | 2.99 | 3.31 | 3.79 | 3.82 | 3.30 | 2.79 |
Sulfonylureas | 41.45 | 38.54 | 37.56 | 35.32 | 32.24 | 29.04 | 26.98 | 24.88 | 22.83 | 21.19 | 20.80 |
Thailand hospital | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â |
Alpha-glucosidase inhibitors | 1.37 | 1.12 | 1.01 | 1.02 | 1.17 | 1.27 | 1.29 | 1.34 | 1.29 | 1.16 | 1.09 |
Biguanides | 41.79 | 45.92 | 48.30 | 49.27 | 50.45 | 52.09 | 54.78 | 55.11 | 55.26 | 55.00 | 56.63 |
DPP4inhibitors | 0 | 0 | 0 | 0 | 0 | 0 | 0.08 | 0.23 | 0.41 | 0.62 | 0.71 |
Fixed dose combinations** | 0 | 0 | 0.01 | 0.05 | 0.08 | 0.12 | 0.20 | 0.31 | 0.40 | 0.49 | 0.68 |
Non-sulfonylurea secretagogues | 0.15 | 0.15 | 0.14 | 0.14 | 0.16 | 0.17 | 0.16 | 0.16 | 0.15 | 0.14 | 0.15 |
Thiazolidinediones | 0.43 | 0.54 | 0.71 | 0.81 | 1.18 | 1.28 | 1.38 | 1.61 | 1.90 | 2.15 | 2.33 |
Sulfonylureas | 56.26 | 52.27 | 49.83 | 48.71 | 46.96 | 45.06 | 42.11 | 41.25 | 40.58 | 40.45 | 38.41 |
Thailand retail | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â |
Alpha-glucosidase inhibitors | 1.83 | 1.58 | 1.30 | 1.11 | 1.98 | 1.92 | 1.69 | 1.73 | 2.28 | 1.86 | 2.75 |
Biguanides | 35.12 | 32.10 | 37.81 | 42.00 | 42.82 | 43.16 | 39.94 | 43.41 | 39.71 | 41.17 | 40.81 |
DPP4 inhibitors | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.16 | 0.62 | 1.31 |
Fixed dose combinations** | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.09 | 0.06 | 0.05 | 0.27 |
Non-sulfonylurea secretagogues | 0 | 0 | 0.19 | 0.22 | 0.38 | 0.41 | 0.47 | 0.50 | 0.50 | 0.43 | 0.50 |
Thiazolidinediones | 0.23 | 0.50 | 0.54 | 0.62 | 0.66 | 0.58 | 0.54 | 1.43 | 1.75 | 1.74 | 2.37 |
Sulfonylureas | 62.82 | 65.82 | 60.16 | 56.06 | 54.16 | 53.93 | 57.35 | 52.83 | 55.54 | 54.12 | 52.00 |